skip to Main Content


Role of Patient Input for Oncology Drug Reviews
An interview with Marjorie Morrison, CEO of the Canadian Cancer Action Network

Listen as Marjorie Morrison, CEO of the Canadian Cancer Action Network, talks about the important role patient advocacy groups are playing in today’s complex drug approval process and how the new Patient Health Technology Assessment Navigator is helping to shape the country’s drug review system.

Key Strategies You Must Know To Survive In Today’s World Of Oncology Clinical Research
Phase Ib Antibody Drug Conjugate Study In Advanced Platinum-Resistant Ovarian Cancer
Phase I/II Targeted Therapeutic Study In Advanced Colorectal Cancer
Phase III Immuno-Oncology Study In Advanced Renal Cell Carcinoma
Phase I/II Advanced HER2+ Breast Cancer Study
Reverse Feasibility In Action
Guide To Accelerating Site Start-Up By 50%
Clinical Cancer Advances 2015
Canadian Cancer Stats 2015
AACR Cancer Progress Report 2015
The Secret To Oncology Clinical Trial Performance
Busting Myths About Canadian Regulatory Review
Centralized Ethics Review For Oncology Trials In Canada
Benefits Of Big Data Analytics In Oncology Clinical Research
Biomarkers & Companion Diagnostics In Oncology Clinical Research
Quality, Speed & Performance – Key Attributes To Canada’s Oncology Clinical Trial Future
Role Of Patient Input For Oncology Drug Reviews
Early Warning Signs: An Ailing Canary In The Mine
Reflections On Medical Oncology: 25 Years Of Clinical Trials – Where Have We Come And Where Are We Going?
Is Investigative Site Feasibility Feasible?
Key Factors In CRO Selection
Selecting The Right Outsourcing Providers For Your Oncology Clinical Trials
Oncology Clinical Development Challenges & Opportunities In The Phase I Setting
Personalized Medicine: How Will The End Of One-size-fits-all Medicine Affect The Clinical Trial Industry?
Ten Trends Transforming The Business Of Oncology
Tapping The Expertise Of Oncology CROs
Oncology Trial Comparator Drug Reimbursement: A Canadian Perspective
Key Strategies You Must Know To Survive In Today’s World Of Oncology Clinical Research
Controlling The Known Variables – Strategies For Solving The Operational Challenges Of Oncology Clinical Trials
What Your CRO Doesn’t Know Could Hurt You – How To Leverage Canada For Study Expansion & Recruitment
A Word From Dr. Stephen Welch – A Reverse Feasibility Champion
Optimizing North America For Your Oncology Trials
Canadian Expansion From A Site’s Perspective
The Secret To Unlocking The True Recruitment Potential Of Canada
The Reverse Feasibility Program Explained
Value Of Canadian Oncology Centers For Early Phase Trials

Sign up to Canadian Oncology Clinical Trial News

Receive updates from our blog, podcasts and resource library.

Back To Top
Close search